Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2567677 | Pulmonary Pharmacology & Therapeutics | 2007 | 10 Pages |
Abstract
Our results suggest that propofol exerts protective effect on the endotoxin-induced ALI. The mechanisms of actions may be mediated through inhibition on the release of pro-inflammatory cytokines, free radicals and NO. In addition, propofol abrogates the microvascular leakage of water and protein in the lungs. The results imply that the use of propofol in critically ill is not only for sedation, but also useful for the prevention of inflammatory progression and lung damage.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Chia-Hsiang Chu, Demeral David Liu, Yung-Hsiang Hsu, Kuan-Chiao Lee, Hsing I Chen,